LPL Financial’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $544K | Buy |
46,945
+432
| +0.9% | +$5K | ﹤0.01% | 4239 |
|
|
2025
Q1 | $406K | Buy |
46,513
+12,742
| +38% | +$111K | ﹤0.01% | 4276 |
|
|
2024
Q4 | $485K | Buy |
33,771
+7,014
| +26% | +$101K | ﹤0.01% | 4054 |
|
|
2024
Q3 | $604K | Buy |
26,757
+8,028
| +43% | +$181K | ﹤0.01% | 3778 |
|
|
2024
Q2 | $364K | Buy |
18,729
+697
| +4% | +$13.6K | ﹤0.01% | 4041 |
|
|
2024
Q1 | $677K | Buy |
18,032
+6,859
| +61% | +$257K | ﹤0.01% | 3477 |
|
|
2023
Q4 | $625K | Buy |
11,173
+3,307
| +42% | +$185K | ﹤0.01% | 3448 |
|
|
2023
Q3 | $324K | Sell |
7,866
-5,802
| -42% | -$239K | ﹤0.01% | 3801 |
|
|
2023
Q2 | $763K | Buy |
13,668
+6,164
| +82% | +$344K | ﹤0.01% | 3063 |
|
|
2023
Q1 | $419K | Sell |
7,504
-7,856
| -51% | -$438K | ﹤0.01% | 3464 |
|
|
2022
Q4 | $560K | Sell |
15,360
-3,067
| -17% | -$112K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $525K | Sell |
18,427
-3,146
| -15% | -$89.6K | ﹤0.01% | 3098 |
|
|
2022
Q2 | $976K | Buy |
21,573
+1,660
| +8% | +$75.1K | ﹤0.01% | 2586 |
|
|
2022
Q1 | $1.52M | Buy |
19,913
+3,611
| +22% | +$275K | ﹤0.01% | 2254 |
|
|
2021
Q4 | $2.43M | Buy |
16,302
+7,425
| +84% | +$1.11M | ﹤0.01% | 1936 |
|
|
2021
Q3 | $1.29M | Sell |
8,877
-751
| -8% | -$109K | ﹤0.01% | 2400 |
|
|
2021
Q2 | $1.89M | Buy |
9,628
+629
| +7% | +$123K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $1.63M | Buy |
8,999
+1,972
| +28% | +$357K | ﹤0.01% | 1993 |
|
|
2020
Q4 | $995K | Buy |
7,027
+3,503
| +99% | +$496K | ﹤0.01% | 2181 |
|
|
2020
Q3 | $439K | Buy |
+3,524
| New | +$439K | ﹤0.01% | 2565 |
|